BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seelig A. P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers. Front Oncol 2020;10:576559. [PMID: 33194688 DOI: 10.3389/fonc.2020.576559] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lerchen H, Stelte-ludwig B, Kopitz C, Heroult M, Zubov D, Willuda J, Schlange T, Kahnert A, Wong H, Izumi R, Hamdy A. A Small Molecule–Drug Conjugate (SMDC) Consisting of a Modified Camptothecin Payload Linked to an αVß3 Binder for the Treatment of Multiple Cancer Types. Cancers 2022;14:391. [DOI: 10.3390/cancers14020391] [Reference Citation Analysis]
2 Moesgaard L, Reinholdt P, Nielsen CU, Kongsted J. Mechanism behind Polysorbates' Inhibitory Effect on P-Glycoprotein. Mol Pharm 2022. [PMID: 35512380 DOI: 10.1021/acs.molpharmaceut.2c00074] [Reference Citation Analysis]
3 Fitzmaurice O, Bartkowski M, Giordani S. Molecular Switches—Tools for Imparting Control in Drug Delivery Systems. Front Chem 2022;10:859450. [DOI: 10.3389/fchem.2022.859450] [Reference Citation Analysis]
4 Feng S, Zhang A, Wu F, Luo X, Zhang J. In-situ growth of boronic acid-decorated metal-organic framework on Fe3O4 nanospheres for specific enrichment of cis-diol containing nucleosides. Analytica Chimica Acta 2022;1206:339772. [DOI: 10.1016/j.aca.2022.339772] [Reference Citation Analysis]
5 Thaker TM, Mishra S, Zhou W, Mohan M, Tang Q, Faraldo-Goméz JD, Mchaourab HS, Tomasiak TM. Asymmetric drug binding in an ATP-loaded inward-facing state of an ABC transporter. Nat Chem Biol 2021. [PMID: 34931066 DOI: 10.1038/s41589-021-00936-x] [Reference Citation Analysis]
6 Guéniche N, Huguet A, Bruyere A, Habauzit D, Le Hégarat L, Fardel O. Comparative in silico prediction of P-glycoprotein-mediated transport for 2010-2020 US FDA-approved drugs using six Web-tools. Biopharm Drug Dispos 2021. [PMID: 34272891 DOI: 10.1002/bdd.2299] [Reference Citation Analysis]
7 Lenoir C, Terrier J, Gloor Y, Gosselin P, Daali Y, Combescure C, Desmeules JA, Samer CF, Reny J, Rollason V. Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. JPM 2022;12:526. [DOI: 10.3390/jpm12040526] [Reference Citation Analysis]
8 Saini N, Grewal AS, Lather V, Gahlawat SK. Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions. Chem Biol Interact 2022;:109901. [PMID: 35341731 DOI: 10.1016/j.cbi.2022.109901] [Reference Citation Analysis]
9 Gericke B, Wienböker I, Brandes G, Löscher W. Is P-Glycoprotein Functionally Expressed in the Limiting Membrane of Endolysosomes? A Biochemical and Ultrastructural Study in the Rat Liver. Cells 2022;11:1556. [DOI: 10.3390/cells11091556] [Reference Citation Analysis]
10 Dai Y, Ni S, Wu F, Guo S, Zhao X, Wang J. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder. J Clin Pharm Ther 2022. [PMID: 35488449 DOI: 10.1111/jcpt.13675] [Reference Citation Analysis]
11 Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Farahani MV, Hushmandi K, Zarrabi A, Goldman A, Ashrafizadeh M, Orive G. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discov Today 2021:S1359-6446(21)00428-1. [PMID: 34624510 DOI: 10.1016/j.drudis.2021.09.020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Guo R, Xu Q, Liu L, Liu H, Liu Y, Wei W, Qin Y. Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway. J Cancer 2021;12:6081-93. [PMID: 34539881 DOI: 10.7150/jca.62285] [Reference Citation Analysis]
13 Wu L, Lian W, Zhao L. Calcium signaling in cancer progression and therapy. FEBS J 2021. [PMID: 34288422 DOI: 10.1111/febs.16133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Magalhães N, Simões GM, Ramos C, Samelo J, Oliveira AC, Filipe HAL, Ramalho JPP, Moreno MJ, Loura LMS. Interactions between Rhodamine Dyes and Model Membrane Systems—Insights from Molecular Dynamics Simulations. Molecules 2022;27:1420. [DOI: 10.3390/molecules27041420] [Reference Citation Analysis]
15 Pitsillou E, Liang JJ, Beh RC, Prestedge J, Catak S, Hung A, Karagiannis TC. Identification of novel bioactive compounds from Olea europaea by evaluation of chemical compounds in the OliveNet™ library: in silico bioactivity and molecular modelling, and in vitro validation of hERG activity. Computers in Biology and Medicine 2022;142:105247. [DOI: 10.1016/j.compbiomed.2022.105247] [Reference Citation Analysis]
16 Mosca L, Pagano M, Borzacchiello L, Mele L, Russo A, Russo G, Cacciapuoti G, Porcelli M. S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation. Int J Mol Sci 2021;22:9286. [PMID: 34502219 DOI: 10.3390/ijms22179286] [Reference Citation Analysis]
17 Madla CM, Qin Y, Gavins FKH, Liu J, Dou L, Orlu M, Murdan S, Mai Y, Basit AW. Sex Differences in Intestinal P-Glycoprotein Expression in Wistar versus Sprague Dawley Rats. Pharmaceutics 2022;14:1030. [DOI: 10.3390/pharmaceutics14051030] [Reference Citation Analysis]
18 Yoon S, Wang X, Vongpunsawad S, Tromp G, Kuivaniemi H. Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer. Front Oncol 2021;11:632657. [PMID: 33816271 DOI: 10.3389/fonc.2021.632657] [Reference Citation Analysis]
19 Chen W, Li C, Shi Y, Zhang Y, Jin D, Zhang M, Bo M, Li G. A Comprehensive Analysis of Metabolomics and Transcriptomics Reveals Novel Biomarkers and Mechanistic Insights on Lorlatinib Crosses the Blood-Brain Barrier. Front Pharmacol 2021;12:722627. [PMID: 34497521 DOI: 10.3389/fphar.2021.722627] [Reference Citation Analysis]